- Gene Therapy Pioneer Jerry R. Mendell, M.D., Named to Inaugural TIME100 Health List of the 100 Most Influential People in Global Health
- Sarepta Therapeutics Announces First Quarter 2024 Financial Results and Recent Corporate Developments
- Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Sarepta Therapeutics to Announce First Quarter 2024 Financial Results
- Sarepta Therapeutics to Present at Upcoming Investor Conferences
- Sarepta Therapeutics Announces Call for Applications for the 7th Annual Route 79, The Duchenne Scholarship Program
- Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Recent Corporate Developments
- Sarepta Therapeutics to Announce Fourth Quarter and Full-Year 2023 Financial Results
More ▼
Key statistics
On Friday, Sarepta Therapeutics Inc (SRPT:NSQ) closed at 131.38, -13.69% below its 52-week high of 152.21, set on May 22, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 132.88 |
---|---|
High | 133.12 |
Low | 129.50 |
Bid | 127.00 |
Offer | 132.99 |
Previous close | 132.74 |
Average volume | 1.09m |
---|---|
Shares outstanding | 94.52m |
Free float | 89.90m |
P/E (TTM) | 1,653.07 |
Market cap | 12.45bn USD |
EPS (TTM) | 0.0797 USD |
Data delayed at least 15 minutes, as of May 17 2024 21:00 BST.
More ▼